Skip to main content
Premium Trial:

Request an Annual Quote

Promega Gets NDIS OK for Multiplex System

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Promega today said that its PowerPlex 18D system has received approval for use by labs generating DNA records for the National DNA Index System.

The NDIS is part of the Federal Bureau of Investigation's Combined DNA Index System. It contains several million offender and forensic DNA profiles contributed by federal, state, and local forensic labs used to identify criminals.

Promega launched the PowerPlex 18D system this past February. The system is an 18-locus, multiplex STR amplification system designed for rapid DNA typing from offender database and familial relationship samples. According to Promega, the system provides direct amplification, eliminating the need for a separate DNA extraction step, while providing a thermal cycling time of less than 90 minutes.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.